What's Stopping GLP-1s From Getting Cheaper
February 10, 2026
46,638
616
82
1.50%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Cnbc Episodes Around February 10, 2026
See what was published immediately before and after this episode.
YouTube Description
as posted by the channelThe push to make weight loss drugs more affordable is running into legal limits. Telehealth company Hims & Hers pulled a less expensive oral version of Wegovy after lawsuits from Novo Nordisk and rising regulatory scrutiny. The dispute centers on pharmaceutical compounding, which is legal for individualized patient needs, and whether it crossed into large-scale marketing. With semaglutide no longer in shortage, Novo says compounded versions are not justified. CNBC's Brandon Gomez reports.
Produced and shot by: Charlotte Morabito
Edited by: Andrea Miller
Reporting by: Brandon Gomez, Annika Kim Constantino
Senior Director of Video: Lindsey Jacobson
Additional Footage: Getty Images
» Subscribe to CNBC TV
» Watch CNBC on the go with CNBC+
About CNBC: From 'Wall Street' to 'Main Street' to award winning original documentaries and Reality TV series, CNBC has you covered. Experience special sneak peeks of your favorite shows, exclusive video and more.
Want to get ahead at work with AI? Sign up for CNBC's new online course, Beyond the BasicsHow to Use AI to Supercharge Your Work. Learn advanced AI skills like building custom GPTs and using AI agents to boost your productivity today. Sign up today
Connect with CNBC News Online
Get the latest news
Follow CNBC on LinkedIn
Follow CNBC News on Instagram
Follow CNBC News on Facebook
Follow CNBC on Threads
Follow CNBC News on X
Follow CNBC on WhatsApp
#CNBC
Why Cheaper GLP-1 Drugs Are Facing Legal Battles
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.